Cargando…
Quantitative determination of decitabine incorporation into DNA and its effect on mutation rates in human cancer cells
Decitabine (5-aza-2′-deoxycytidine) is a DNA methyltransferase inhibitor and an archetypal epigenetic drug for the therapy of myeloid leukemias. The mode of action of decitabine strictly depends on the incorporation of the drug into DNA. However, DNA incorporation and ensuing genotoxic effects of de...
Autores principales: | Öz, Simin, Raddatz, Günter, Rius, Maria, Blagitko-Dorfs, Nadja, Lübbert, Michael, Maercker, Christian, Lyko, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231731/ https://www.ncbi.nlm.nih.gov/pubmed/25159616 http://dx.doi.org/10.1093/nar/gku775 |
Ejemplares similares
-
RNA cytosine methylation analysis by bisulfite sequencing
por: Schaefer, Matthias, et al.
Publicado: (2009) -
Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method
por: Liu, Zhongfa, et al.
Publicado: (2007) -
Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16(INK4A) promoter in colon carcinoma cell lines
por: Mund, Cora, et al.
Publicado: (2005) -
Incorporating cell hierarchy to decipher the functional diversity of single cells
por: Chen, Lingxi, et al.
Publicado: (2022) -
Multiplex SNP typing by bioluminometric assay coupled with terminator incorporation (BATI)
por: Zhou, Guo-Hua, et al.
Publicado: (2005)